Literature DB >> 14625231

Bronchospasm precipitated by ethanol injection in arteriovenous malformation.

Tiscia B Stefanutto1, Van Halbach.   

Abstract

We present an interesting case of profound bronchospasm that we postulate was caused by injection of ethanol during embolization of a left transverse sinus dural fistula. There is excellent documentation in the literature of the development of transient pulmonary hypertension and decreased right-side cardiac output following embolization with this agent; however, there have been only anecdotal reports of a temporal relationship between ethanol embolization and bronchospasm. We present this case that occurred on the third ethanol embolization treatment series.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625231      PMCID: PMC8148910     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  7 in total

Review 1.  Treatment of acute anaphylaxis.

Authors:  M Fisher
Journal:  BMJ       Date:  1995-09-16

2.  Anaphylactoid shock--a common cause of death in heroin addicts?

Authors:  E Edston; M van Hage-Hamsten
Journal:  Allergy       Date:  1997-09       Impact factor: 13.146

3.  Fatal cardiovascular collapse during ethanol sclerotherapy of a venous malformation.

Authors:  R Chapot; A Laurent; O Enjolras; D Payen; E Houdart
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

4.  Ethanol endovascular management of brain arteriovenous malformations: initial results.

Authors:  W F Yakes; L Krauth; J Ecklund; R Swengle; J N Dreisbach; C E Seibert; R Baker; M Miller; G VanderArk; T Fullagar; E Prenger
Journal:  Neurosurgery       Date:  1997-06       Impact factor: 4.654

Review 5.  Embolotherapy: agents, clinical applications, and techniques.

Authors:  D M Coldwell; K R Stokes; W F Yakes
Journal:  Radiographics       Date:  1994-05       Impact factor: 5.333

6.  Mast cell tryptase in anaesthetic anaphylactoid reactions.

Authors:  M M Fisher; B A Baldo
Journal:  Br J Anaesth       Date:  1998-01       Impact factor: 9.166

7.  The pathology of arteriovenous malformations of the brain treated by embolotherapy. II. Results of embolization with multiple agents.

Authors:  J S Schweitzer; B S Chang; P Madsen; F Viñuela; N A Martin; C E Marroquin; H V Vinters
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

  7 in total
  6 in total

1.  Transvenous ethanol sclerotherapy of feeding arteries for treatment of a dural arteriovenous fistula.

Authors:  Matthew David Alexander; Van Halbach; Andrew Nicholson; Fabio Settecase; Robert J Darflinger; Matthew R Amans
Journal:  BMJ Case Rep       Date:  2016-07-15

2.  Transvenous ethanol sclerotherapy of feeding arteries for treatment of a dural arteriovenous fistula.

Authors:  Matthew David Alexander; Van Halbach; Andrew Nicholson; Fabio Settecase; Robert J Darflinger; Matthew R Amans
Journal:  J Neurointerv Surg       Date:  2016-07-20       Impact factor: 5.836

3.  Unilateral bronchospasm during microcatheter manipulation in an interventional neuroradiology suite.

Authors:  Kiran Reddy; Hemanshu Prabhakar; Naveen Yadav; Gyaninder Pal Singh; Zulfiqar Ali
Journal:  J Anesth       Date:  2010-01-26       Impact factor: 2.078

4.  A Step-by-Step Practical Approach to Imaging Diagnosis and Interventional Radiologic Therapy in Vascular Malformations.

Authors:  Gerald M Legiehn; Manraj K S Heran
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

5.  Head and neck arteriovenous malformations: results of ethanol sclerotherapy.

Authors:  J Pekkola; K Lappalainen; P Vuola; T Klockars; P Salminen; A Pitkäranta
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-05       Impact factor: 3.825

6.  Superselective Intra-Arterial Ethanol Sclerotherapy of Feeding Artery and Nidal Aneurysms in Ruptured Cerebral Arteriovenous Malformations.

Authors:  F Settecase; S W Hetts; A D Nicholson; M R Amans; D L Cooke; C F Dowd; R T Higashida; V V Halbach
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-12       Impact factor: 3.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.